Recent Updates
Recently added Catalysts
ESTA Positive Sentiment

Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

Monday, October 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Establishment Labs Holdings Inc. has received FDA approval for an expanded range of Motiva SmoothSilk breast implants. This approval includes 28 new sizes, enhancing the options available for patients in the U.S. market. The move is expected to improve women's health and wellness in breast aesthetics and reconstruction.

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA approval enhances product offerings.
  • Expanded range meets diverse patient needs.
  • Strengthens market position in breast aesthetics.

Full Press Release Details

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded range of Motiva SmoothSilk® Round and Motiva SmoothSilk Ergonomix® breast implants for use in the United States. The approval adds 28 new sizes to the Motiva U.S. portfolio, including implants as sm

Frequently Asked Questions

What did Establishment Labs receive FDA approval for?

They received FDA approval for an expanded range of Motiva breast implants.

How many new sizes were added to Motiva implants?

The approval adds 28 new sizes to the Motiva U.S. portfolio.

What types of Motiva implants were approved?

The approved implants include Motiva SmoothSilk Round and Ergonomix.

What is the focus of Establishment Labs?

Establishment Labs focuses on improving women's health in breast aesthetics and reconstruction.

ShareAdd on Google
Tags: ESTA Establishment Labs Motiva implants FDA approval breast aesthetics women's health
Last updated: Oct 5, 2026

Biotech snapshot

Cash runway
$71M liquidity · $6M/mo burn
~11 mo
Medium dilution risk